ZBH - Zimmer Biomet Holdings Inc Stock Analysis
Zimmer Biomet Holdings Inc (ZBH) is a publicly traded company listed on the NYSE. It operates in the Medical Devices industry, part of the broader Healthcare sector. The company has a market capitalization of 18.46B, generates annual revenue of 8.01B, and reports net income of 805.10M. As of the latest data, the stock is trading at 93.16 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The dividend yield (0.97%) is modest, often associated with growth-oriented companies. This stock tends to be less volatile than the overall market, often preferred by conservative investors.
Analyst recommendation stands at Hold (3.5), indicating current market sentiment. Institutional ownership is reported at 99.76%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -15.69%, trading within a 52-week range of 85.33 - 114.44.
ZBH - Zimmer Biomet Holdings Inc
93.16
Analyst Consensus
Hold 3.5
ZBH – Analyst Rating Summary
- Strong Buy: 6
- Buy: 7
- Hold: 19
- Sell: 2
- Strong Sell: 0
- Total Analysts: 34
| Index: | S&P 500 | P/E: | 23.05 | EPS (ttm): | 4.04 | Insider Own: | 0.14% | Shs Outstand: | 198.20M | Perf Week: | -4.50% |
| Market Cap: | 18.46B | Forward P/E: | 10.94 | EPS next Y: | 8.51 | Insider Trans: | -2.12% | Shs Float: | 197.90M | Perf Month: | -9.71% |
| Income(ttm): | 805.10M | PEG: | 5.16 | EPS next Q: | 2.40 | Inst Own: | 99.76% | Short Float: | 3.81% | Perf Quarter: | -11.89% |
| Revenue(ttm): | 8.01B | P/S: | 2.30 | EPS this Y: | 2.16% | Inst Trans: | 0.77% | Short Ratio: | 4.29 | Perf Half Y: | 1.35% |
| Book/sh: | 64.36 | P/B: | 1.45 | EPS next Y: | 4.15% | ROA: | 3.56% | Short Interest: | 7.55M | Perf Year: | -15.69% |
| Cash/sh: | 6.52 | P/C: | 14.28 | EPS next 5Y: | 4.47% | ROE: | 6.41% | 52W Range: | 85.33 - 114.44 | Perf YTD: | -11.81% |
| Dividend Est.: | 0.91 (0.97%) | P/FCF: | 15.30 | EPS past 3/5Y: | 32.42% -4.13% | ROIC: | 3.97% | 52W High: | 114.44 -18.59% | Beta: | 0.62 |
| Dividend TTM: | 0.96 (1.03%) | Quick Ratio: | 1.39 | Sales past 3/5Y: | 3.99% -0.77% | Gross Margin: | 62.61% | 52W Low: | 85.33 9.18% | Perf 5Y: | -35.99% |
| Dividend Ex-Date: | Sep 30, 2025 | Current Ratio: | 2.43 | EPS Y/Y TTM: | -23.03% | Oper. Margin: | 18.39% | RSI (14): | 46.64 | Volatility: | 2.10% 2.73% |
| Employees: | 17000 | Debt/Eq: | 0.64 | Sales Y/Y TTM: | 5.47% | Profit Margin: | 10.05% | Recom: | 2.63 | Target Price: | 101.88 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.59 | EPS Q/Q: | -5.35% | Payout: | 21.66% | Rel Volume: | 1.24 | Prev Close: | 93.10 |
| Sales Surprise: | -0.52% | EPS Surprise: | 1.82% | Sales Q/Q: | 9.71% | Earnings: | Nov 05 BMO | Avg Volume: | 1.76M | Price: | 93.16 |
| SMA20: | 1.59% | SMA50: | -3.32% | SMA200: | -5.88% | Undervalued: 9.36% | Volume: | 2,177,459 | Change: | 0.06% | |
Graham Classic formula value: 63.27
(P/E=8 * 1g) Min value: 45.24
(current P/E * 2g) Max value: 116.05
Average value: 74.85
About Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.